- Greg Jones | September 16, 2009 10:18 AM | Charlotte, NC
Category:
Miscellaneous
The first trial over Merck & Co. Inc.'s osteoporosis drug Fosamax has ended in a mistrial Friday after the jury told the court it was deadlocked and unable to reach a unanimous verdict.
The...
- Jean Martin | September 03, 2009 10:08 AM | Wilmington, NC
Category:
FDA & Prescription Drugs
Closing arguments were held yesterday in the first trial against Merck concerning the osteoporosis drug Fosamax. Millions of women have taken Fosamax to counter bone loss associated with menopause....
- Greg Jones | September 01, 2009 3:12 PM | Charlotte, NC
Category:
FDA & Prescription Drugs
Merck & Co. Inc., the manufacturer of the osteoporosis drug Fosamax, has asked a federal judge to dismiss the remaining claims in a product liability and personal injury. The Plaintiff, Boles, a...
- Greg Jones | August 13, 2009 2:32 PM | Charlotte, NC
Category:
FDA & Prescription Drugs
Merck faces the first trial due to lawsuits based on its osteoporosis drug Fosamax allegedly causing the death of jawbone tissue. The Fosamax plaintiffs claim Merck misrepresented the drug’s...
- Jean Martin | April 29, 2008 12:41 PM | Wilmington, NC
Category:
FDA & Prescription Drugs
A study has found that women who use the drug Fosamax are twice as likely to develop an irregular heartbeat condition known as atrial fibrillation as women who have never taken the drug. The 86%...